A matched cohort study in Inflammatory Bowel Diseases found remission odds nearly six times higher on GLP-1 drugs, and weight loss alone didn't explain it.
Recap by typeshit. Full story at Medical Dialogues.
The review looks at concerns about misuse as demand for GLP-1 drugs grows, and points to how little evidence guides their use beyond approved conditions.
Researchers found self-reported GLP-1 use climbed from March 2024 to October 2025, mostly for weight loss, through channels insurance data may not capture.
The study is looking for women with hot flashes and night sweats and a BMI above 30. Mayo Clinic has the full eligibility rules and how to sign up.
She says women with endometriosis taking GLP-1 drugs tell her bloating, pain and fatigue feel better. These are patient reports, not trial results.
A rundown on the pill version of Wegovy, covering what form it comes in and its availability. Thin on details, so tap through for the specifics.
No weigh-in this time, just a personal check-in saying the journey is going well so far, plus one thing they've noticed along the way.
Loading…